Best Practices for Treatment of Invasive Methicillin-Susceptible Staphylococcus aureus Infections: The Case for Oxacillin

J Pediatric Infect Dis Soc. 2016 Dec;5(4):480-482. doi: 10.1093/jpids/piw052. Epub 2016 Sep 7.

Authors

James B Wood¹, Isaac P Thomsen¹, C Buddy Creech¹, Jason G Newland²

Affiliations

¹ Vanderbilt Vaccine Research Program, Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee.
² Division of Pediatric Infectious Diseases, Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri.

PMID: 27609072
DOI: 10.1093/jpids/piw052

No abstract available

Keywords: Staphylococcus aureus; cefazolin; inoculum effect; invasive staphylococcal disease; oxacillin.

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Humans
Oxacillin / therapeutic use*
Staphylococcal Infections / drug therapy*
Staphylococcus aureus / drug effects

Substances

Anti-Bacterial Agents
Oxacillin